Leone Patterson

Ms. Patterson joined Tenaya in June 2021 as Chief Financial and Business Officer, leading corporate finance, investor relations, corporate communications, strategy and business development, as well as other operational functions. Ms. Patterson joined Tenaya from Adverum Biotechnologies where she served as President and Chief Financial Officer, and previously held the positions of CEO and Director. Prior to Adverum, Ms. Patterson was Chief Financial Officer at both Diadexus and Transcept. She also held senior finance positions at Exelixis, Novartis and Chiron. Earlier in her career she worked in the audit practice of accounting firm KPMG.

Currently, Ms. Patterson also serves on the board of directors of Nkarta, Inc., a publicly-held clinical-stage biopharmaceutical company and Eliem Therapeutics a private biotech company. Ms. Patterson earned a B.S. in business administration and accounting from Chapman University and an executive M.B.A. from St. Mary’s College. Ms. Patterson is also a Certified Public Accountant (inactive status).